P552-02
P552-02 is an epithelial sodium channel (ENaC) inhibitor. P552-02 blocks ENaC function in humans, guinea pigs, rats and sheep, exhibits the characteristic of reduced dissociation rate after binding to ENaC, inhibits ENaC-mediated short-circuit current, and slows the absorption of airway surface liquid (ASL). P552-02 induces hyperkalemia in guinea pigs and rats, blocks the activity of airway ENaC in guinea pigs, and enhances mucociliary clearance in sheep both in vivo and in vitro. P552-02 is applicable to cystic fibrosis-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 587879-32-1
- Formel: C19H26ClN7O4
- Molecular Weight:451.91
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
P552-02 potently inhibits ENaC-mediated short-circuit current in primary human bronchial cells (pIC50 = 8.62), guinea pig ENaC (pIC50 = 8.42), and rat ENaC (pIC50 = 8.46), and exerts strong inhibitory activity against wild-type human ENaC in transfected FRT cells with a pIC50 of 8.85; mutations at the amiloride binding site drastically reduce its potency, with 4316-fold and 435-fold pIC50 shifts for αβG525Aγ and αβγG537C respectively[1].
P552-02 (250 nM; 2-10 min) exerts a moderately long-lasting blocking effect on ENaC in primary human bronchial epithelial cells, with 73.7% recovery of ISC after 2 min of incubation at 250 nM and 82.9% recovery after 10 min of incubation[1].
P552-02 potently inhibits ENaC-mediated short-circuit current in cultured human bronchial epithelial cells; it blocks the sustained absorption of airway surface liquid (ASL) in vitro, and acts synergistically with hypertonic saline to maintain the hydration state of ASL without blocking aquaporins[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | CL | Vss | T1/2 |
|---|---|---|---|---|---|
| Rat[1] | 1 mg/kg | i.v. | 149 mL/min/kg | 19.7 L/kg | 3.8 h |
In Vivo
P552-02 (200-2000 μg/kg; intratracheal administration; single dose) induces dose-dependent hyperkalemia in rats following intratracheal administration[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Dunkin Hartley (male, 300-650 g)[1]
-
Dosage:0.2 μg/kg (TPD assessment at 1 h); 128 μg/kg (TPD assessment at 4 h)
-
Administration:i.t.; single dose
-
Result:Attenuated tracheal potential difference with an ED50 of 0.2 μg/kg at 1 h after dosing.
Retained airway ENaC-blocking activity with an ED50 of 128 μg/kg at 4 h after dosing.
Induced a significant elevation in blood potassium levels relative to vehicle control at doses ≥ 60 μg/kg.
-
Animal Model:Sprague-Dawley (male, 250-350 g)[1]
-
Dosage:200, 600, 2000 μg/kg
-
Administration:i.t.; single dose
-
Result:Induced significant increases in blood potassium levels relative to vehicle control at 600 μg/kg (mean maximum level 6.53 mmol/L) and 2000 μg/kg (mean maximum level 6.95 mmol/L).
Chemical Information
-
CAS. Nr. 587879-32-1
-
Molecular Weight 451.91
-
Formel C19H26ClN7O4
-
SMILES
O=C(NC(=N)NCCCCC1=CC=C(OCC(O)CO)C=C1)C2=NC(Cl)=C(N=C2N)N
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Protocol for Pharmacokinetic Study
Pharmacokinetic studies quantify how an organism handles a drug over time through absorption, distribution, metabolism, and excretion, and the core experimental readout is the concentration-time profile of parent drug and, when relevant, metabolites in biological matrices such as plasma, whole blood, urine, bile, or tissue. Pharmacokinetic analysis links dose, route, exposure, clearance, half-life, distribution, bioavailability, and systemic exposure to drug efficacy and toxicity hypotheses rather than measuring a signaling pathway directly. The literature links pharmacokinetics to drug-development phenotypes by showing that drug metabolism and pharmacokinetics influence compound progression, exposure-response interpretation, safety margins, dosing strategy, and failure risk during discovery and development. DMPK science contributes to compound optimization by integrating physicochemical properties, in vitro metabolism, transporter behavior, in vivo exposure, and pharmacodynamic contex
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)